Herpes simplex virus in the pediatric bone marrow and stem cell transplantation patient  by Blackstock, J.L. et al.
285
PREADMISSION STEM CELL TRANSPLANTATION TEACHING: A TEAM
APROACH
Scherer, T.M., Wheeler, A. Christiana Care Health System, Newark,
DE.
The Hematology Care Coordination team addresses the educa-
tional and psychosocial needs of transplantation patients in a mul-
tidisciplinary fashion. Central to this formal education plan is the
unique partnership of the Oncology-Certiﬁed RN Hematology
Care Coordinator and Social Worker who assess these needs
throughout the continuum of care. The process centers around a
patient/caregiver educational meeting, at which time a comprehen-
sive participative needs assessment is completed, goals are devel-
oped, and interventions are initiated.
Due to the complexity of the transplantation process, adequate
patient and caregiver education is crucial. The Care Coordination
team recognized that our current process lacked multidisciplinary
coordination. Our purpose was to develop a coordinated assess-
ment process to identify immediate and future educational and
psychosocial needs and to develop an educational plan that fosters
patient/caregiver empowerment. It was anticipated by our team
that this educational program would result in a better understand-
ing and compliance with team recommendations.
It was identiﬁed that earlier referrals to the Care Coordination
team were necessary. The weekly multidisciplinary bone marrow
transplantation meeting now serves as the initial referral to the
Care Coordination team. The treatment plan is completed col-
laboratively by the transplantation team. This plan provides initial
insight into the educational and psychosocial needs of the patient/
caregiver.
Before the patient/caregiver meeting, an educational binder is
individualized based on transplantation type. This binder guides
the format and content of the meeting. A needs assessment to
investigate knowledge, ﬁnancial, and psychosocial issues of the
patient/caregiver is performed, and an exclusive teaching plan is
immediately initiated. After the meeting, referrals are made to
ancillary support services for continued assessment and education.
We have found that our up-front assessment and screening fol-
lowed by individual instruction have contributed to a more suc-
cessful learning experience. Our patients have verbalized a marked
decrease in anxiety and increase in knowledge, which has facilitated
a better compliance with the treatment plan. The physicians con-
cur based on assessment of anxiety, knowledge, and understanding
on signing the informed consent. This project stresses the impor-
tance of the nurse’s role in patient education, which can be dupli-
cated in various practice settings.
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COMBINED HOME ENZYME REPLACEMENT THERAPY AND UNRELATED
CORD BLOOD TRANSPLANTATION FOR HURLER’S SYNDROME (MPSI)
IN A PEDIATRIC HSCT CENTER
Rodriguez, M.1, Khimji, I.2, Rhodd, S.2, Lapage, C.2, Zalesky, L.3,
Jimenez, P.3, Barbouth, D.1, Elsas, L.1, Kleiner, G.1 1/ University of
Miami School of Medicine, Miami, FL; 2Jackson Memorial Hospital,
Miami, FL; 3Accredo Therapeutics, Fort Lauderdale, FL.
Hurler’s syndrome is caused by mutations in the alpha iduroni-
dase gene and results in progressive deterioration of the central
nervous system. Allogeneic bone marrow transplantation before
age 2 years halts disease progression and prolongs life. Enzyme
replacement therapy (ERT) reduces lysosomal storage of mucopo-
lysaccharides in the liver and ameliorates extracranial manifesta-
tions of the disease. In most instances, ERT is done in a day-
hospital setting. Because enzyme replacement therapy can mitigate
airway and pulmonary manifestation of MPS I, we hypothesized
that ERT in the peritransplantation period (pre-HSCT and im-
mediately post-HSCT) would decrease transplantation-related
complications.
We performed combined ERT and HSCT in a 12-month-old
boy with MPSI. The patient received his ﬁrst dose of Aldurazyme
at age 5 months, shortly after MPSI diagnosis. He had received 16
infusions before referral to our center. Throughout his pretrans-
plantation workup, the patient received ERT at the local Trans-
plantation House by a visiting nurse. There were no infusion-
related toxicities. The patient received a 5/6 unrelated cord blood
unit and engrafted on day 12. Hyperacute GVHD was treated
successfully with high-dose methylprednisolone pulse. After en-
graftment, the child received 8 additional doses of Aldurazyme.
Four initial infusions were performed in the pediatric bone marrow
transplantation unit following in-service by pediatric BMT nurse
and pediatric BMT pharmacist. The remainder of his 4 infusions
were performed at the local Transplantation House.
We conclude that in this ﬁrst case of combined outpatient ERT
infusion with HSCT, pretransplantation and posttransplantation
ERT does not interfere with engraftment. Further studies are
needed to determine whether progressive neurodegeneration is
altered.
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THE NURSING SHORTAGE: THE DUKE PEDIATRIC STEM CELL TRAN-
PLANT PROGRAM NURSING RECRUITMENT AND RETENTION PRO-
GRAM
Frey, M.A., Talbert, G. Duke University Pediatric Stem Cell Trans-
plant Program, Durham, NC.
Health care organizations are in the midst of a severe and pro-
found nursing shortage that is expected to intensify as “baby
boomers” age and the need for health care grows. Nursing pro-
grams across the country are struggling to expand enrollment
levels to meet the rising demand for nursing care. According to the
latest projections from the U.S. Department of Labor Statistics
published in the February 2004 Monthly Labor Review, more than 1
million new and replacement nurses will be needed by 2012. For
the ﬁrst time, the U.S. Department of Labor has identiﬁed regis-
tered nursing as the top occupation in terms of job growth through
the year 2012. The need for registered nurses has dramatically and
negatively impacted patient care. According to a study published in
the Journal of the American Medical Association in October 2002,
nurses reported greater job dissatisfaction and emotional exhaus-
tion when they were responsible for more patients than they can
safely care for. Lead researcher Dr. Linda Aiken concluded that
“failure to retain nurses contributes to avoidable patient deaths.”
Another published study by Dr. Aiken (Health Affairs, May/June
2001) concluded that  40% of nurses working in hospitals re-
ported being dissatisﬁed with their jobs. The study also concluded
that 1 of every 3 hospital nurses under age 30 are planning to leave
their current job within the next year.
The purpose of this abstract is to describe the Duke Pediatric
Stem Cell Transplant Program’s Nursing and Retention Program.
This program was developed in 1998 in an effort to recruit and
retain top talent in a unit that had historically sustained chronic
nursing vacany rates  30%. Before the inception of this program,
the pediatric inpatient unit had to close beds due to the shortage of
qualiﬁed nurses. Since the implementation of this plan, there is
now a waiting list of qualiﬁed applicants. The plan involves a fully
developed shared governance model, staff involvement in decision
making on the unit, and dedicated funding for retention opportu-
nities that support the inpatient nursing staff.
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HERPES SIMPLEX VIRUS IN THE PEDIATRIC BONE MARROW AND STEM
CELL TRANSPLANTATION PATIENT
Blackstock, J.L., Parikh, S.H., Talbert, J.G. Pediatric Bone Marrow/
Stem Cell Transplant, Duke University Medical Center, Durham, NC.
Herpes simplex is a viral infection that usually produces small,
temporary irritating, and sometimes painful ﬂuid-ﬁlled blisters on
the skin and mucous membranes. Primary herpes simplex virus
(HSV) infection usually occurs in early childhood, after which time
the virus becomes latent. Reactivation is more likely to occur
during periods of immunosuppression. Bone marrow and stem cell
transplantation recipients’ host immune systems are ablated before
transplantation, and thus every aspect of the immune system is
deﬁcient. HSV infection can be devastating when it occurs in
immunocompromised patients. Herpes simplex in patients with
compromised immune systems can cause serious, perhaps life-
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threatening complications. Prophylactic acyclovir is routinely
given to patients, which has lessened the prevalence of HSV. When
HSV does not respond to acyclovir, or is found to be resistant to
acyclovir, foscarnet has proven to be a powerful antiviral agent;
however, foscarnet can be very toxic to renal function. This poster
will include general information on this virus and treatments used
to control it, along with nursing considerations for the care of the
pediatric transplantation patient with a reactivation of HSV infec-
tion.
289
ASSESSING FOR NUTRITIONAL RISK FACTORS ON A BONE MARROW
TRANSPLANTATION UNIT
Szewczyk, N.A. University of Texas M.D. Anderson Cancer Center,
Houston, TX.
The Assessing for Nutritional Risk Factors clinical project took
place in a bone marrow transplantation (BMT) unit in San Anto-
nio, Texas. The purpose of this project is to develop an assessment
tool for identifying individuals in a BMT inpatient unit who are at
risk for developing complications secondary to inadequate nutri-
tional intake. A secondary goal of this project is to increase nutri-
tional assessment documentation by the nursing staff in this unit.
The Nutritional Risk Assessment Tool (NRAT) preevaluation data
were obtained by interviewing the staff regarding their opinions
about malnutrition in the oncology patient population and the
usefulness of the NRAT on the BMT unit. In addition, the doc-
umentation rate of calorie counts and weights was collected for the
3 months before this project’s implementation.
Results showed a signiﬁcant increase in calorie count documen-
tation and an overall increase in the staff’s awareness about mal-
nutrition in this patient population. The outcomes of this project
include (1) increased awareness of nutritional deﬁcits in the BMT
population in multidisciplinary team members including RNs,
PCAs, and MDs; (2) increased documentation of inadequate di-
etary assessment; and (3) pilot testing of a nutritional assessment
tool.
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SUBJECTIVE SYMPTOMS AND PERFORMANCE STATUS OF SURVIVORS
OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
Choi, S.E., Kim, K.S., Bok, G.N. St. Mary’s Hospital, Catholic HSCT
Center, Seoul, Korea.
Hematopoietic stem cell transplantation(HSCT) is a widely
used treatments for hematologic malignancies and has often
ensured long-term survival of HSCT patients. Concern for
“quality of life” in HSCT patients has increased, and a quality of
life issue becomes recognized as an important outcome of the
treatment. These patients and their families are expecially in-
terested in when they are going to return to “normal” life and
how much time it will take. Therefore, we examined post-
HSCT patients’ subjective symptoms and performance status as
indicators of quality of life.
The ﬁnal samples consisted of 250 patients who had undergone
HSCT at a single center from 1990 to October 2003 and survived
at least 1 year after receiving HSCT. Of the 250 patients, 142 were
male and 108 were female, with a mean age of 33 years. Of the total
patients, 113 patients (59.5%) had been married and 73 patients
(38.4%) wre been single at the time of HSCT.
The patients completed a questionnaire mailed by the research-
ers. Subjective symptom subscales include fatigue, nausea and vom-
iting, pain, dyspnea, insomnia, loss of appetite, constipation, diar-
rhea, and ﬁnancial difﬁculties. The scores of subjective symptoms
range from 0 to 100, with higher scores indicating more severe
symptoms. Performance status was measured in patients over age
16 years using the Karnofsky score and in those under age 16 years
using the Lansky scale.
The median score of subjective symptom after HSCT was 12.2
(range, 0–68.8). The subjective symptom which many of the pa-
tients complained about was ﬁnancial difﬁculties (median, 40),
followed by fatigue (median, 30) and insomnia (median, 17.3). By
3 years, those symptoms had gradually decreased.
The median score of performance status 1–3 years after HSCT
was 80%, but 3 years later it was 90%, indicating that as time went
on, performance status improved. Among the 114 patients who had
been employed before HSCT, 81 (71.1%) continued to work but
30 (26.3%) became unemployed after HSCT. The average time to
return to school and work was 1.27 years (range, 1 to 7 years);
within 2 years after HSCT, 80 patients (72.7%) returned.
In conclusion, those ﬁndings can suggest that until 3 years fol-
lowing HSCT, there should be steady management of physical
symptoms and complications which post-HSCT patients possibly
experience.
Table. Subjective Symptoms and Performance Status after HSCT
1–<2
Year
2–<3
Year
3–4
< Year
4–<5
Year
5 <
Year
Financial
Difficulties 43.00 50.60 38.30 35.70 28.70
Fatigue 38.80 40.60 37.90 27.50 33.40
Subjective
Symptoms 18.90 22.20 15.20 12.00 12.90
Performance
Status 80.10 81.70 90.00 93.20 93.40
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TREATMENT OPTIONS AND NURSING CARE FOR THE PEDIATRIC
APLASTIC ANEMIA PATIENT REQURIRING BONE MARROW OR STEM
CELL TRANSPLANTATION
Baker, J.H., Frey, M.A., Kurtzberg, J. Duke University Medical Cen-
ter, Durham, NC.
Aplastic anemia is a rare, potentially lethal disease that occurs
when the bone marrow stops making enough blood cells. The
condition results in complete bone marrow failure and aplasia.
Common life threatening complications include infection, bleed-
ing, and anemia. The cause of aplastic anemia is unknown but may
be linked to injury to the bone marrow from radiation, chemicals,
viruses, and other causes. The initial diagnosis of aplastic anemia is
often a medical emergency requiring hospitalization and isolation.
The diagnosis is typically made via peripheral blood sampling and
a bone marrow aspirate. Supportive care during the initial period
typically consists of blood component replacement and antimicro-
bial coverage to reduce and treat life-threatening infections. The
gold standard of cure for these patients is bone marrow or stem cell
transplantation. The Duke Pediatric Stem Cell Transplant Pro-
gram has performed 22 transplantations on children with aplastic
anemia. The aims ofthis abstract are as follows:
1. To deﬁne and describe the potential causes of aplastic anemia.
2. To describe the symptoms associated with the onset of the disease, as
well as the sequelae seen with the progression of this disease.
3. To review the latest treatment options, including a detailed analysis of
bone marrow and stem cell transplantation in this patient population.
4. To provide a detailed description of the Duke Pediatric Stem Cell
Transplantation experience regarding this patient population.
5. To provide statistics on the outcomes of transplantation in this group
of children.
6. To identify nursing strategies for the care and support of these patients.
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OPEN ALL NIGHT? VISITING HOURS ON BONE MARROW TRANSPLAN-
TATION UNITS
Rees, L.F. H. Lee Mofﬁtt Cancer Center & Research Institute, Tampa,
FL.
Established visitation policies exist to provide a safe environment,
yet they may be at odds with the psychological needs of patients.
Bone marrow transplantation (BMT) patients experience pro-
longed neutropenia, resulting in protracted lengths of stay. Fami-
lies/caregivers wish to show psychological support by increased
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